315 related articles for article (PubMed ID: 8752167)
21. Photodynamic therapy of human ovarian epithelial carcinoma, OVCAR-3, heterotransplanted in the nude mouse.
Peterson CM; Reed R; Jolles CJ; Jones KP; Straight RC; Poulson AM
Am J Obstet Gynecol; 1992 Dec; 167(6):1852-5. PubMed ID: 1471709
[TBL] [Abstract][Full Text] [Related]
22. Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells.
Hongrapipat J; Kopecková P; Liu J; Prakongpan S; Kopecek J
Mol Pharm; 2008; 5(5):696-709. PubMed ID: 18729468
[TBL] [Abstract][Full Text] [Related]
23. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.
Omelyanenko V; Kopecková P; Gentry C; Kopecek J
J Control Release; 1998 Apr; 53(1-3):25-37. PubMed ID: 9741911
[TBL] [Abstract][Full Text] [Related]
24. Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model.
Molpus KL; Kato D; Hamblin MR; Lilge L; Bamberg M; Hasan T
Cancer Res; 1996 Mar; 56(5):1075-82. PubMed ID: 8640764
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of disulfide-linked HPMA copolymer-mesochlorin e6 conjugates.
Cuchelkar V; Kopecková P; Kopecek J
Macromol Biosci; 2008 May; 8(5):375-83. PubMed ID: 18215003
[TBL] [Abstract][Full Text] [Related]
26. Time- and concentration-dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells.
Demoy M; Minko T; Kopecková P; Kopecek J
J Control Release; 2000 Oct; 69(1):185-96. PubMed ID: 11018556
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates.
Kasuya Y; Lu ZR; Kopecková P; Minko T; Tabibi SE; Kopecek J
J Control Release; 2001 Jul; 74(1-3):203-11. PubMed ID: 11489496
[TBL] [Abstract][Full Text] [Related]
28. The effects of subcellular localization of N-(2-hydroxypropyl)methacrylamide copolymer-Mce(6) conjugates in a human ovarian carcinoma.
Tijerina M; Kopecková P; Kopecek J
J Control Release; 2001 Jul; 74(1-3):269-73. PubMed ID: 11489506
[TBL] [Abstract][Full Text] [Related]
29. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R
Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of starlike N-(2-hydroxypropyl)methacrylamide copolymers: potential drug carriers.
Wang D; Kopecková JP; Minko T; Nanayakkara V; Kopecek J
Biomacromolecules; 2000; 1(3):313-9. PubMed ID: 11710118
[TBL] [Abstract][Full Text] [Related]
31. Gamma scintigraphy of the biodistribution of 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in mice with transplanted melanoma and mammary carcinoma.
Pimm MV; Perkins AC; Strohalm J; Ulbrich K; Duncan R
J Drug Target; 1996; 3(5):375-83. PubMed ID: 8866656
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo evaluation of Radachlorin(R) sensitizer for photodynamic therapy.
Douillard S; Olivier D; Patrice T
Photochem Photobiol Sci; 2009 Mar; 8(3):405-13. PubMed ID: 19255683
[TBL] [Abstract][Full Text] [Related]
33. Preparation of Fab' from murine IgG2a for thiol reactive conjugation.
Fowers KD; Callahan J; Byron P; Kopecek JI
J Drug Target; 2001; 9(4):281-94. PubMed ID: 11697031
[TBL] [Abstract][Full Text] [Related]
34. PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination.
Satchi-Fainaro R; Hailu H; Davies JW; Summerford C; Duncan R
Bioconjug Chem; 2003; 14(4):797-804. PubMed ID: 12862433
[TBL] [Abstract][Full Text] [Related]
35. New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting.
Chytil P; Etrych T; Konák C; Sírová M; Mrkvan T; Boucek J; Ríhová B; Ulbrich K
J Control Release; 2008 Apr; 127(2):121-30. PubMed ID: 18304673
[TBL] [Abstract][Full Text] [Related]
36. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
37. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line.
Minko T; Kopecková P; Pozharov V; Kopecek J
J Control Release; 1998 Jul; 54(2):223-33. PubMed ID: 9724909
[TBL] [Abstract][Full Text] [Related]
38. Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.
Etrych T; Chytil P; Mrkvan T; Sírová M; Ríhová B; Ulbrich K
J Control Release; 2008 Dec; 132(3):184-92. PubMed ID: 18534705
[TBL] [Abstract][Full Text] [Related]
39. Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate.
Del Governatore M; Hamblin MR; Shea CR; Rizvi I; Molpus KG; Tanabe KK; Hasan T
Cancer Res; 2000 Aug; 60(15):4200-5. PubMed ID: 10945630
[TBL] [Abstract][Full Text] [Related]
40. Sequential combination therapy of ovarian cancer with degradable N-(2-hydroxypropyl)methacrylamide copolymer paclitaxel and gemcitabine conjugates.
Zhang R; Yang J; Sima M; Zhou Y; Kopeček J
Proc Natl Acad Sci U S A; 2014 Aug; 111(33):12181-6. PubMed ID: 25092316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
